Managing Supraclavicular Disease from Breast Cancer with Brachial Plexus-sparing Techniques using Helical Tomotherapy

Clinical Oncology

Volumn 23, Issue 2, 2011, Pages 101-107

  Chatterjee, S ^a   Lee, D ^a   Kent, N ^a   Wintle, T ^a   Mott, J H ^a   Kelly, C G ^a   Branson, A N ^a  

^a FREEMAN HOSPITAL   (United Kingdom)

Author keywords

Brachial plexus sparing helical tomotherapy; Breast cancer; Supraclavicular fossa salvage

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; FLUORODEOXYGLUCOSE F 18;

ADJUVANT CHEMOTHERAPY; ADULT; ADVANCED CANCER; ARTICLE; BRACHIAL PLEXUS; BREAST CANCER; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURGERY; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FEMALE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTRADUCTAL CARCINOMA; MASTECTOMY; MUSCULOSKELETAL DISEASE; PRIORITY JOURNAL; SUPRACLAVICULAR FOSSA DISEASE; TOMOTHERAPY;

ADULT; BRACHIAL PLEXUS; BREAST NEOPLASMS; CLAVICLE; FEASIBILITY STUDIES; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; ORGANS AT RISK; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, INTENSITY-MODULATED; SALVAGE THERAPY; TREATMENT OUTCOME;

EID: 79251606514     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2010.09.009     Document Type: Article

References (25)

1. Beavis A.W. Is tomotherapy the future of IMRT?. Br J Radiol 2004, 77:285-295.
2. Mackie T.R. History of tomotherapy. Phys Med Biol 2006, 51:R427-R453.
3. Lee N., Puri D.R., Blanco A.I., Chao K.S. Intensity-modulated radiation therapy in head and neck cancers: an update. Head Neck 2007, 29:387-400.
4. Ahmed M., Hansen V.N., Harrington K.J., Nutting C.M. Reducing the risk of xerostomia and mandibular osteoradionecrosis: the potential benefits of intensity modulated radiotherapy in advanced oral cavity carcinoma. Med Dosim 2009, 34:217-224.
5. Bhide S., Clark C., Harrington K., Nutting C. Intensity modulated radiotherapy improves target coverage and parotid gland sparing when delivering total mucosal irradiation in patients with squamous cell carcinoma of head and neck of unknown primary site. Med Dosim 2007, 32:188-195.
6. Hall W.H., Guiou M., Lee N.Y., et al. Development and validation of a standardized method for contouring the brachial plexus: preliminary dosimetric analysis among patients treated with IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2008, 72:1362-1367.
7. Graham P., Jagavkar R., Browne L., Millar E. Supraclavicular radiotherapy must be limited laterally by the coracoid to avoid significant adjuvant breast nodal radiotherapy lymphoedema risk. Australas Radiol 2006, 50(6):578-582.
8. Gosk J., Rutowski R., Urban M., Wiacek R., Rabczynski J. Brachial plexus injuries after radiotherapy - analysis of 6 cases. Folia Neuropathol 2007, 45(1):31-35.
9. Gałecki J., Hicer-Grzenkowicz J., Grudzień-Kowalska M., Michalska T., Załucki W. Radiation-induced brachial plexopathy and hypofractionated regimens in adjuvant irradiation of patients with breast cancer-a review. Acta Oncol 2006, 45(3):280-284.
10. Chatterjee S, Mott JH, Smyth G, Dickson S, Dobrowsky W, Kelly CG. Clinical challenges in the implementation of a tomotherapy service for head and neck cancer patients in a regional UK radiotherapy centre. Br J Radiol (in press).
11. Emami B., Lyman J., Brown A., et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991, 21:109-122.
12. Bajrovic A., Rades D., Fehlauer F., et al. Is there a life-long risk of brachial plexopathy after radiotherapy of supraclavicular lymph nodes in breast cancer patients?. Radiother Oncol 2004, 71:297-301.
13. Goddu S.M., Chaudhari S., Mamalui-Hunter M., et al. Helical tomotherapy planning for left-sided breast cancer patients with positive lymph nodes: comparison to conventional multiport breast technique. Int J Radiat Oncol Biol Phys 2009, 73(4):1243-1251.
14. Intensity Modulated and Partial Organ Radiotherapy (IMPORT) High Trial Planning Pack. Final version Available at:. http://rttrialsqa.dnsalias.org/IMPORT%20HIGH.htm.
15. Bentzen S.M., Agrawal R.K., Aird E.G., Barrett J.M., Barrett-Lee P.J. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol 2008, 4:331-341. START Trialists' Group.
16. Johansson S. Radiation induced brachial plexopathies. Acta Oncol 2006, 45(3):253-257.
17. Friberg S., Rudén B.I. Hypofractionation in radiotherapy. An investigation of injured Swedish women, treated for cancer of the breast. Acta Oncol 2009, 48(6):822-831.
18. Miles E.A., Venables K., Hoskin P.J., Aird E.G.A. Dosimetry and field matching for radiotherapy to the breast and supraclavicular fossa. Radiother Oncol 2009, 91:42-48. on behalf of the START Trial Management Group.
19. Caudrelier J.M., Morgan S.C., Montgomery L., Lacelle M., Nyiri B., Macpherson M. Helical tomotherapy for locoregional irradiation including the internal mammary chain in left-sided breast cancer: dosimetric evaluation. Radiother Oncol 2009, 90(1):99-105.
20. Gonzalez V.J., Buchholz D.J., Langen K.M., et al. Evaluation of two tomotherapy-based techniques for the delivery of whole-breast intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 2006, 65(1):284-290.
21. Coon A.B., Dickler A., Kirk M.C., et al. Tomotherapy and multifield intensity-modulated radiotherapy planning reduce cardiac doses in left-sided breast cancer patients with unfavorable cardiac anatomy. Int J Radiat Oncol Biol Phys 2010, 78(1):104-110.
22. O'Donnell H., Cooke K., Walsh N., Plowman P.N. Early experience of tomotherapy-based intensity-modulated radiotherapy for breast cancer treatment. Clin Oncol (R Coll Radiol) 2009, 21(4):294-301.
23. Ashenafi M., Boyd R.A., Lee T.K., et al. Feasibility of postmastectomy treatment with helical tomotherapy. Int J Radiat Oncol Biol Phys 2010, 77(3):836-842.
24. Huang E.H., Strom E.A., Valero V., et al. Locoregional treatment outcomes for breast cancer patients with ipsilateral supraclavicular metastases at diagnosis. Int J Radiat Oncol Biol Phys 2007, 67(2):490-496.
25. Forquer J.A., Fakiris A.J., Timmerman R.D., et al. Brachial plexopathy from stereotactic body radiotherapy in early-stage NSCLC: dose-limiting toxicity in apical tumor sites. Radiother Oncol 2009, 93(3):408-413.